TMEI:CA:TSX-

| International Equity |

Last Closing

CAD 1.79

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.15M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-05 )

Largest Industry Peers for International Equity

Symbol Name Price(Change) Market Cap
ZEA:CA BMO MSCI EAFE

+0.09 (+0.39%)

CAD 8.42B
XEF:CA iShares Core MSCI EAFE IMI

+0.22 (+0.57%)

CAD 8.40B
VIU:CA Vanguard FTSE Developed All Ca..

+0.15 (+0.43%)

CAD 4.29B
TPE:CA TD International Equity Index ..

+0.10 (+0.42%)

CAD 1.55B
XFH:CA iShares Core MSCI EAFE IMI Ind..

-0.11 (-0.34%)

CAD 1.45B
XIN:CA iShares MSCI EAFE (CAD Hedged)

-0.12 (-0.32%)

CAD 1.36B
QDX:CA Mackenzie International Equity..

+0.88 (+0.74%)

CAD 0.89B
ZDM:CA BMO MSCI EAFE (CAD Hedged)

-0.10 (-0.33%)

CAD 0.82B
VEF:CA Vanguard FTSE Developed All Ca..

-0.14 (-0.24%)

CAD 0.64B
HXDM:CA Global X Intl Developed Market..

+0.27 (+0.57%)

CAD 0.58B

ETFs Containing TMEI:CA

UC48:LSE UBSs plc - MSCI AC Asia E.. 0.00 % 0.00 %

+75.50 (+0.56%)

USD 0.30B

Market Performance

  Market Performance vs. Industry/Classification (International Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -88.69% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -88.69% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -88.13% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -88.13% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.15% N/A N/A N/A N/A
Dividend Return 0.19% N/A N/A N/A N/A
Total Return 0.04% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.12% N/A N/A N/A N/A
Risk Adjusted Return 1.60% N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike